Affiliation:
1. Department of Chemistry, Yale University, New Haven, CT 06520, USA.
2. Process Chemistry Development, Takeda Pharmaceuticals International Co., Cambridge, MA 02139, USA.
Abstract
A P catalyst for stereogenic P(III)
Phosphodiesters, the key linkage in DNA, RNA, and bioactive oligonucleotide and cyclic nucleotides, are typically synthesized from phosphoramidite precursors. Phosphorothioate linkages, which are more stable, can also be produced this way but have the complication of chirality at the P center, which is synthetically problematic, especially for multiple linkages. Featherston
et al.
found that two different chiral phosphoric acid catalysts provide stereodivergent synthesis of a stereogenic phosphite intermediate that can be oxidatively modified to the desired stereopure nucleotide derivative. They used this approach in the synthesis of a phosphorothioate derivative of the cyclic dinucleotide 2′,3′-cyclic guanosine monophosphate adenosine monophosphate, which is an important human immune signaling molecule.
Science
, this issue p.
702
Funder
National Institute of General Medical Sciences
Takeda Pharmaceuticals International Co.
Publisher
American Association for the Advancement of Science (AAAS)
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献